Biomarin Pharmaceutical (BMRN) Total Debt (2012 - 2026)

Biomarin Pharmaceutical's (BMRN) quarterly Total Debt came in at $1.4 billion in Q1 2026, up 139.51% on a QoQ basis from $597.2 million in Q4 2025.

Biomarin Pharmaceutical (BMRN) Total Debt (2012 - 2026) Analysis & Trends

Biomarin Pharmaceutical (BMRN) has 14 years of Total Debt data on file, last reported at $1.4 billion in Q1 2026.

  • Quarterly Total Debt changed N/A year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (changed N/A YoY) and the FY2025 annual result came in at $597.2 million, changed N/A from the prior year.
  • Total Debt rose to $1.4 billion in Q1 2026, from $597.2 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $1.4 billion in Q1 2026 to a low of $15.9 million in Q4 2022.
  • A 5-year average of $405.4 million and a median of $493.9 million in 2023 frame the typical range for Total Debt.
  • Annual changes were most pronounced in 2022 — Total Debt sank 66.98% — and 2023, when it surged 3001.27%.
  • Tracing BMRN's Total Debt over 5 years: stood at $15.9 million in 2022, then surged by 3001.27% to $493.9 million in 2023, then increased by 0.19% to $494.8 million in 2024, then advanced by 20.68% to $597.2 million in 2025, then soared by 139.51% to $1.4 billion in 2026.
  • The last three Total Debt figures came in at $1.4 billion (Q1 2026), $597.2 million (Q4 2025), and $494.8 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.07 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.34 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 546.77 Mn
10 Biomarin Pharmaceutical 13.04 Bn 12.16 Bn 786.91 Mn 4.84 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.84 Bn
Mar 31, 2026 1.43 Bn
Dec 31, 2025 597.18 Mn
Jun 30, 2024 494.84 Mn
Mar 31, 2024 494.36 Mn
Dec 31, 2023 493.88 Mn
Dec 31, 2022 15.93 Mn
Sep 30, 2022 28.30 Mn
Jun 30, 2022 29.95 Mn
Mar 31, 2022 64.00 Mn
Dec 31, 2021 48.23 Mn
Sep 30, 2021 48.20 Mn
Jun 30, 2021 32.20 Mn
Mar 31, 2021 30.81 Mn
Sep 30, 2020 374.29 Mn
Jun 30, 2020 370.10 Mn
Mar 31, 2020 365.96 Mn
Dec 31, 2019 361.88 Mn
Sep 30, 2019 10.00 Mn
Jun 30, 2019 9.93 Mn